Share >  
Share
Share on Tumblr

Cefuroxime Axetil Tablets

News »

   latest by relevance
Will end current yr with Rs 1000cr rev: Nectar Lifesciences
Sep 30, 2010 at 15:13 | Source: CNBC-TV18
Nectar Lifesciences has got an approval from the EU for Cefuroxime Axetil. In an interview with CNBC-TV18's Latha Venkatesh and Reema Tendulkar, Dinesh Dua, CEO of Nectar Lifesciences spoke on the approval, the opportunity it throws up for the company and his expectations on revenue growth for the current fiscal and the next.
Aurobindo Pharma gets okay for Cefuroxime Axetile Tablets
Mar 03, 2010 at 15:05 | Source: Moneycontrol.com
Aurobindo Pharma has got Canada okay for Cefuroxime Axetile Tablets, quoting NewsWire18, reports CNBC-TV18. It touched an intra day high of Rs 948.80 and an intra day low of Rs 916.30. At 14:59 hrs the share was quoting at Rs 938.00, up Rs 15.85, or 1.72%.
Orchid receives US FDA approval for Cefuroxime Axetil ANDA
Feb 20, 2008 at 11:59
Orchid Chemicals & Pharmaceuticals Ltd announced that it has received approval from the US FDA for its ANDA for Cefuroxime Axetil Tablets. The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
Ranbaxy gets USFDA nod for generic Ceftin
Feb 08, 2008 at 08:30 | Source: Business Line
Ranbaxy Laboratories Ltd has received US Food and Drug Administration approval to make and sell the generic version of GlaxoSmithKlines anti-infective Ceftin, which will be the first generic formulation in the market, reports Business Line.
Ranbaxy gets approval to mfg,mkt Cefuroxime Axetil
Feb 06, 2008 at 19:20
Ranbaxy gains approval to manufacture and market Cefuroxime Axetil for oral suspension in USA
Aurobindo Pharma acquires US-based cGMP
Jul 10, 2006 at 12:35
Aurobindo Pharma has acquired USFDA compliant cGMP facility. Director of Aurobindo Pharma Limited, Lanka Srinivas says that the total consideration paid for the facility is less than USD 25 million.

Videos »
Will end current yr with Rs 1000cr rev: Nectar Lifesciences
more »

Photos »

  /  

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window